Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study

被引:23
|
作者
Herrero, Jesus-Miguel [1 ,2 ]
Vega, Pablo [1 ,2 ]
Salve, Maria [1 ,2 ]
Bujanda, Luis [3 ]
Cubiella, Joaquin [1 ,2 ]
机构
[1] Complexo Hosp Univ Ourense, Dept Gastroenterol, Orense, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed Galicia Sur, Orense, Spain
[3] Univ Basque Country UPV EHU, CIBERehd, Donostia Hosp, Biodonostia Inst, San Sebastian, Spain
来源
BMC GASTROENTEROLOGY | 2018年 / 18卷
关键词
Colorectal cancer; Faecal immunochemical test; Diagnostic accuracy; Risk stratification; HEMOGLOBIN CONCENTRATION; INDICATORS; ACCURACY; DISEASE; SYSTEM;
D O I
10.1186/s12876-018-0887-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundSymptom based referral criteria for colorectal cancer (CRC) detection are the cornerstone of the strategy to improve prognosis in CRC. In 2017, the National Institute for Health and Care Excellence (NICE) updated their referral criteria (2017 NG12). Recently, several studies have evaluated the faecal haemoglobin (f-Hb) concentration in this setting. The aim of this study is to evaluate the diagnostic accuracy of the 2017 NG12 referral criteria and to compare them with the CG27 referral criteria, the f-Hb concentration and two f-Hb based prediction model: COLONPREDICT and FAST Score.MethodsThis is a post-hoc diagnostic test study performed within the COLONPREDICT study database (1572 patients, CRC prevalence 13.6%). We assessed symptoms, the 2017 NG12 and CG27 referral criteria and determined the f-Hb before performing a colonoscopy. We compared the discriminatory ability using the area under the curve (AUC) and the sensitivity and specificity at pre-stablished thresholds with the McNemar's test.ResultsThe 2017 NG12 referral criteria discriminatory ability (AUC 0.53; 95% confidence interval- CI 0.49-0.57) was inferior to the CG27 version (AUC 0.59; 95% CI 0.55-0.63; p=0.01), the f-Hb concentration (AUC 0.86; 95% CI 0.84-0-89; p<0.001), the COLONPREDICT Score (AUC 0.92; 95% CI 0.91-0.94; p<0.001) or the FAST Score (AUC 0.87; 95% CI 0.85-0.89; p<0.001). The number of patients meeting each criteria were as follows: 2017 NG12 and CG27=94.1% and 52.2%; f-Hb 20 and10g/g faeces=38.6 and 44.3%; COLONPREDICT Score5.6 and3.2=29.4 and 63.2% and FAST Score4.50 and2.12=37.1 and 87.0%. The 2017 NG12 criteria were more sensitive (100%) than the CG27 criteria (68.2%), the f-Hb (20g/g) (91.2%), the f-Hb (10g/g) (93.5%), the COLONPREDICT Score (5.6) (90.1%) and the FAST Score (4.50) (89.8%) (p0.001) and equivalent to the COLONPREDICT Score (3.5) (99.5%) or the FAST Score (2.12) (100.0%) (p=1). However, their specificity (6.8%) was significantly lower than any of the evaluated criteria (50.3%, 69.6%, 63.4%, 78.7%, 45.8%, 71.3%, 13.9%; p<0.001).ConclusionReferral criteria based on f-Hb measurement, either as a single test or within prediction models, are more accurate than symptom-based referral criteria for CRC detection in symptomatic patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms
    Dancourt, Vincent
    Lejeune, Catherine
    Lepage, Come
    Gailliard, Marie Claude
    Meny, Bernard
    Faivre, Jean
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (15) : 2254 - 2258
  • [42] Incorporating faecal haemoglobin measurement using the faecal immunochemical test (FIT) in the referral, triage, and prioritisation pathway for patients with colorectal symptoms
    Falvey, James
    Frampton, Chris M. A.
    Gearry, Richard B.
    Hudson, Ben
    Whiteley, Lucinda
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2023, 136 (1578) : 55 - 76
  • [43] Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients
    Widlak, M. M.
    Thomas, C. L.
    Thomas, M. G.
    Tomkins, C.
    Smith, S.
    O'Connell, N.
    Wurie, S.
    Burns, L.
    Harmston, C.
    Evans, C.
    Nwokolo, C. U.
    Singh, B.
    Arasaradnam, R. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (02) : 354 - 363
  • [44] Faecal immunochemical tests for the diagnosis of symptomatic colorectal cancer in primary care: the benefit of more than one sample
    Hogberg, Cecilia
    Soderstrom, Lars
    Lilja, Mikael
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017, 35 (04) : 369 - 372
  • [45] Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy
    Tsapournas, Georgios
    Hellstrom, Per M.
    Cao, Yang
    Olsson, Louise I.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) : 184 - 192
  • [46] Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test
    Portillo, Isabel
    Arana-Arri, Eunate
    Gutierrez-Ibarluzea, Inaki
    Bilbao, Isabel
    Luis Hurtado, Jose
    Sarasqueta, Cristina
    Idigoras, Isabel
    Bujanda, Luis
    Hurtado, Jose Luis
    de No, Carmen
    Enciso, Carlos
    Escalante, Maite
    Francisco Erana, Luis
    Atares, Begona
    Javier Aguirre, Jose
    Pereda, Esther
    Maranon, Edurne
    Otazua, Pedro
    Fernandez, Maria
    Francisco Egido, Jose
    Zapata, Eva
    Zubiaurre, Leire
    Mari Rodriguez, Juana
    Esteban Sampedro, Pedro
    Goyeneche, Marisa
    Maria Arrinda, Jose
    Milagros Gomez, Mari Carmen
    Luz Jauregui, Mari
    Gomez, Marta
    Saiz, Marta
    Rotaeche, Rafael
    Gutierrez-Stampa, Maria A.
    Aguilar-Gama, Vanessa
    Bujanda, Luis
    Gil, Ines
    Banales, Jesus
    Perugorria, Maria J.
    D'Amato, Mauro
    Sarasqueta, Cristina
    Herreros-Villanueva, Marta
    Gutierrez-Stampa, Marian
    Aguilar-Gama, Vanessa
    Montalvo, Isabel
    Miguel Larzabal, Jose
    Garmendia, Maddi
    Izquierdo, Fernando
    Javier Fernandez, Francisco
    Rodriguez, Iago
    Huerta, Alain
    de Miguel, Eduardo
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 (06): : 1143 - 1148
  • [47] Performance of the faecal immunochemical test for the detection of colorectal neoplasms and the role of proton pump inhibitors in their diagnostic accuracy
    Chandrapalan, Subashini
    Hee, Siew Wan
    Widlak, Monika M.
    Farrugia, Alexia
    Alam, Mohammed T.
    Smith, Steve
    Arasaradnam, Ramesh P.
    [J]. COLORECTAL DISEASE, 2021, 23 (07) : 1649 - 1657
  • [48] Accuracy of a faecal immunochemical test in patients under colonoscopy surveillance of colorectal adenoma and cancer
    Olsson, Louise
    Sjoberg, Daniel
    [J]. UPSALA JOURNAL OF MEDICAL SCIENCES, 2023, 128 (01)
  • [49] Are hemoglobin levels really lower in faecal immunochemical test positive patients with colorectal cancer?
    Ng, Jing Yu
    Tan, Ian Jse-Wei
    Tan, Ker-Kan
    [J]. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2018, 16 (01): : 36 - 39
  • [50] Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community
    Hughes, K
    Leggett, B
    Del Mar, C
    Croese, J
    Fairley, S
    Masson, J
    Aitken, J
    Clavarino, A
    Janda, M
    Stanton, WR
    Tong, SL
    Newman, B
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2005, 29 (04) : 358 - 364